Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms
Clinical trial NCT03541200 · COMPLETED
Trial details
- NCT number
- NCT03541200
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-18
- Primary completion
- 2019-11-15
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.